EDITAS MEDICINE, INC. Stock Issued
EDITAS MEDICINE, INC. (EDIT) reported Stock Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2026-03-09
- EDITAS MEDICINE, INC. stock issued for the quarter ending 2021-03-31 was $27.50M.
- EDITAS MEDICINE, INC. stock issued for the quarter ending 2018-09-30 was -$12.50M.
- EDITAS MEDICINE, INC. stock issued for the quarter ending 2018-06-30 was $12.50M.
- EDITAS MEDICINE, INC. stock issued for the quarter ending 2018-03-31 was $9.53M.
- EDITAS MEDICINE, INC. stock issued for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- EDITAS MEDICINE, INC. stock issued for fiscal 2024 was $1.48M.
- EDITAS MEDICINE, INC. stock issued for fiscal 2023 was $0.00.
- EDITAS MEDICINE, INC. stock issued for fiscal 2022 was $0.00.
| Period end | Stock Issued 3 month | Stock Issued 6 month | Stock Issued 6 month as first filed | Stock Issued 9 month | Stock Issued 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-09 | ||||
| 2024-12-31 | $1.48M 10-K · filed 2026-03-09 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-05 | ||||
| 2022-12-31 | $0.00 10-K · filed 2025-03-05 | ||||
| 2021-03-31 | $27.50M 10-Q · filed 2021-05-06 | ||||
| 2020-12-31 | $27.50M 10-K · filed 2023-02-22 | ||||
| 2018-09-30 | -$12.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $9.53M 10-Q · filed 2019-11-12 | $9.53M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $12.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $22.03M 10-Q · filed 2019-08-07 | $9.53M 10-Q · filed 2018-08-07 | $22.03M derived: sum of 3 quarters · filed 2019-08-07 | |
| 2018-03-31 | $9.53M 10-Q · filed 2019-05-08 | $9.53M derived: sum of 2 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $14.82M 10-K · filed 2018-03-08 | |||
| 2017-09-30 | $14.82M 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |